Suchergebnisse - "BNT162 Vaccine"

PubPharm (1.885)

1

Real-world evidence for the effectiveness and breakthrough of BNT162b2 mRNA COVID-19 vaccine at a medical center in Japan

enthalten in: Human vaccines & immunotherapeutics | 2022

von Naito, T. | Yan, Y. | Tabe, Y. | +2

2

COVID-19 vaccination in 5-11 years old children : Drivers of vaccine hesitancy among parents in Quebec

enthalten in: Human vaccines & immunotherapeutics | 2022

von Dubé, E. | Gagnon, D. | Pelletier, C.

3

COVID-19 vaccine uptake and effectiveness in adults aged 50 years and older in Wales UK : a 1.2m population data-linkage cohort approach

enthalten in: Human vaccines & immunotherapeutics | 2022

von Perry, M. | Gravenor, M. | Cottrell, S. | +9

4

Adverse events of special interest following the use of BNT162b2 in adolescents : a population-based retrospective cohort study

enthalten in: Emerging microbes & infections | 2022

von Lai, F. | Chua, G. | Chan, E. | +11

5

Pfizer-BioNTech (BNT162b2), Moderna (mRNA-1273) COVID-19 mRNA vaccines and hypersensitivity reactions

enthalten in: Journal of the National Medical Association | 2022

von Haq, H. | Khan, H. | Chaudhry, H. | +4

6

Comment on : COVID-19 vaccine (mRNA BNT162b2) and COVID-19 infection-induced thrombotic thrombocytopenic purpura in adolescents

enthalten in: Pediatric blood & cancer | 2022

von Sookaromdee, P. | Wiwanitkit, V.

CommentOn: Pediatr Blood Cancer. 2022 Jun;69(6):e29681. - PMID 35373880

7

Safety of mRNA BNT162b2 COVID-19 (Pfizer-BioNtech) vaccine in children aged 5-11 years : Correspondence

enthalten in: Human vaccines & immunotherapeutics | 2022

von Mungmunpuntipantip, R. | Wiwanitkit, V.

CommentOn: Hum Vaccin Immunother. 2022 Nov 30;18(6):2126668. - PMID 36315849

8

Liver injury after SARS-CoV-2 vaccination : Features of immune-mediated hepatitis, role of corticosteroid therapy and outcome

enthalten in: Hepatology (Baltimore, Md.) | 2022

von Efe, C. | Kulkarni, A. | Terziroli Beretta-Piccoli, B. | +49

9

BNT162b2 mRNA COVID-19 vaccine three-dose safety and risk of COVID-19 in patients with myasthenia gravis during the alpha, delta, and omicron waves

enthalten in: Journal of neurology | 2022

von Doron, A. | Piura, Y. | Vigiser, I. | +4

10

Immune Response to SARS-CoV-2 Third Vaccine in Patients With Rheumatoid Arthritis Who Had No Seroconversion After Primary 2-Dose Regimen With Inactivated or Vector-Based Vaccines

enthalten in: The Journal of rheumatology | 2022

von Isnardi, C. | Cerda, O. | Landi, M. | +27

CommentIn: J Rheumatol. 2022 Dec;49(12):1305-1306. - PMID 36243410

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[189]